Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.

Conditions:   Peripheral T-Cell Lymphoma, Not Otherwise Specified;   Angioimmunoblastic T-cell Lymphoma Interventions:   Drug: Rituximab;   Drug: Gemcitabine;   Drug: Dexamethasone;   Drug: Cisplatin;   Drug: PD-1 monoclonal antibody Sponsors:   Ou Bai, MD/PHD;   Second Hospital of Jilin University;   China-Japan Union Hospital, Jilin University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials